Nectar Lifesciences Limited — Updates, 21-01-2026: General Updates
21-01-2026 | 06:43 pm
21-01-2026 | 06:43 pm
Nectar Lifesciences completed its buyback, extinguishing 3 Cr equity shares (INR 1 face value) at INR 27/share. This reduced total paid-up equity capital from INR 22.43 Cr to INR 19.43 Cr, impacting per-share metrics.
No comments yet. Be the first to comment!
